2,493
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

The Prediction of Deterioration of Nutritional Status during Chemoradiation Therapy in Patients with Esophageal Cancer

, , , &
Pages 229-235 | Received 30 Apr 2017, Accepted 06 Oct 2017, Published online: 11 Jan 2018

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet‐Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015. doi:10.3322/caac.21262.
  • Duan X-F, Tang P, and Yu Z-T: Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review. Cancer Biol Med 11, 191–201, 2014.
  • Heijl M, Lanschot J, Koppert L, Henegouwen MB, Muller K, et al.: Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg 8, 1, 2008.
  • Mariette C, De Botton M-L, and Piessen G: Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice? Ann Surg Oncol 19, 2128–2134, 2012. doi:10.1245/s10434-012-2225-6.
  • Van Cutsem E, and Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9, S51–S63, 2005. doi:10.1016/j.ejon.2005.09.007.
  • Adenis A, Tresch E, Dewas S, Romano O, Messager M, et al.: Clinical complete responders to definite chemoradiation or radiation therapy for esophageal cancer: predictors of outcome. BMC Cancer 13, 1, 2013. doi:10.1186/1471-2407-13-413.
  • Andreyev H, Norman A, Oates J, and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34, 503–509, 1998. doi:10.1016/S0959-8049(97)10090-9.
  • Bozzetti F: Nutritional support in patients with esophageal cancer. Support Care Cancer 18, 41–50, 2010. doi:10.1007/s00520-009-0664-9.
  • Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, et al.: Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis Esophagus 27, 560–567, 2014. doi:10.1111/j.1442-2050.2012.01441.x.
  • Zemanova M, Novak F, Vitek P, Pazdro A, Smejkal M, et al.: Outcomes of patients with esophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors. J BUON 17, 310–316, 2012.
  • Jiang N, Zhao J-Z, Chen X-C, Li L-Y, Zhang L-J, et al.: Clinical determinants of weight loss in patients with esophageal carcinoma during radiotherapy: a prospective longitudinal view. Asian Pac J Cancer Prev 15, 1943–1948, 2013. doi:10.7314/APJCP.2014.15.5.1943.
  • Cox S, Powell C, Carter B, Hurt C, Mukherjee S, et al.: Role of nutritional status and intervention in esophageal cancer treated with definitive chemoradiotherapy: outcomes from SCOPE1. Br J Cancer 115, 172–177, 2016. doi:10.1038/bjc.2016.129.
  • Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, et al.: Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol 21, 3675–3679, 2014. doi:10.1245/s10434-014-3737-z.
  • Lee JLC, Leong LP, Lim SL: Nutrition intervention approaches to reduce malnutrition in oncology patients: a systematic review. Support Care Cancer 24, 469–480, 2016. doi:10.1007/s00520-015-2958-4.
  • Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, et al.: Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer. Dis Esophagus 27, 560–567, 2014. doi:10.1111/j.1442-2050.2012.01441.x.
  • Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, et al.: Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected esophageal or gastro-esophageal junction cancer. Eur Radiol 26(5), 1–9, 2015.
  • Gibson RS. Principles of Nutritional Assessment. USA: Oxford University Press, 2005.
  • Cederholm T, Bosaeus I, Barazzoni R, Bauer J, Van Gossum A, et al.: Diagnostic criteria for malnutrition–an ESPEN consensus statement. Clin Nutr 34, 335–340, 2015. doi:10.1016/j.clnu.2015.03.001.
  • Daabiss M: American society of anaesthesiologists physical status classification. Indian J Anaesth 55, 111, 2011. doi:10.4103/0019-5049.79879.
  • Rice TW, Blackstone EH, and Rusch VW: of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol 17, 1721–1724, 2010. doi:10.1245/s10434-010-1024-1.
  • Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C: Single prediction equation for bioelectrical impedance analysis in adults aged 20–94 years. Nutrition 17, 248–253, 2001. doi:10.1016/S0899-9007(00)00553-0.
  • Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, et al.: Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr 92, 612–619, 2010. doi:10.3945/ajcn.2010.29215.
  • Bohannon RW, Peolsson A, Massy-Westropp N, Desrosiers J, and Bear-Lehman J: Reference values for adult grip strength measured with a Jamar dynamometer: a descriptive meta-analysis. Physiotherapy 92, 11–15, 2006. doi:10.1016/j.physio.2005.05.003.
  • FAO. Energy and Protein Requirements: Report of a Joint FAO/WHO/UNU Expert Consultation. World Health Organization, 1985.
  • Buskermolen S, Langius JA, Kruizenga HM, Ligthart-Melis GC, Heymans MW, et al.: Weight loss of 5% or more predicts loss of fat-free mass during palliative chemotherapy in patients with advanced cancer: a pilot study. Nutr Cancer 64, 826–832, 2012. doi:10.1080/01635581.2012.690062.
  • Halpern-Silveira D, Susin LRO, Borges LR, Paiva SI, Assunção MCF, et al.: Body weight and fat-free mass changes in a cohort of patients receiving chemotherapy. Support Care Cancer 18, 617–625, 2010. doi:10.1007/s00520-009-0703-6.
  • Mendes MCS, Pimentel GD, Costa FO, and Carvalheira JB: Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol 226, R29–R43, 2015. doi:10.1530/JOE-15-0170.
  • Engelen M, Safar A, Bartter T, Koeman F, and Deutz N: High anabolic potential of essential amino acid mixtures in advanced non-small cell lung cancer. Ann Oncol 26(9), mdv271, 2015.
  • Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, et al.: Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutr 98, 1012–1019, 2013. doi:10.3945/ajcn.113.060228.
  • Al-Majid S, and McCarthy DO: Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs 2, 186–197, 2001. doi:10.1177/109980040100200304.
  • Ahlberg K, Ekman T, Gaston-Johansson F, and Mock V: Assessment and management of cancer-related fatigue in adults. Lancet 362, 640–650, 2003. doi:10.1016/S0140-6736(03)14186-4.
  • Frankenfield DC, and Ashcraft CM: Estimating energy needs in nutrition support patients. JPEN J Parenter Enteral Nutr 35, 563–570, 2011. doi:10.1177/0148607111415859.
  • Weijs PJ, Cynober L, DeLegge M, Kreymann G, Wernerman J, et al.: Proteins and amino acids are fundamental to optimal nutrition support in critically ill patients. Crit Care 18, 1–13, 2014. doi:10.1186/s13054-014-0591-0.
  • Leistra E, Willeboordse F, Visser M, Weijs PJ, Haans-van den Oord A, et al.: Predictors for achieving protein and energy requirements in undernourished hospital patients. Clin Nutr 30, 484–489, 2011. doi:10.1016/j.clnu.2011.01.008.